Viral co-infections among SARS-CoV-2-infected children and infected adult household contacts.


Journal

European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 29 07 2020
accepted: 14 01 2021
revised: 07 01 2021
pubmed: 28 1 2021
medline: 24 6 2021
entrez: 27 1 2021
Statut: ppublish

Résumé

We evaluated the rates of viral respiratory co-infections among SARS-CoV-2-infected children. Twelve percent of SARS-CoV-2-infected children had viral co-infection with one or more common respiratory viruses. This was significantly more frequent than among their SARS-CoV-2-infected adult household contacts (0%; p=0.028). Compared to the same period the previous year, common respiratory viruses were less frequently detected (12% vs 73%, p<0.001).Conclusion: Despite partial lockdown with school and daycare closure, and consequently similar exposure to common viruses between children and adults, SARS-CoV-2-infected children had more frequent viral respiratory co-infections than their SARS-CoV-2-infected adult household contacts. Circulation of common respiratory viruses was less frequent during the SARS-CoV-2 outbreak when compared to the same period last year, showing the impact of partial lockdown on the circulation of common viruses. What is Known: • Viral respiratory co-infections are frequent in children. • SARS-CoV-2 can be identified alongside other respiratory viruses, but data comparing children and adults are lacking. What is New: • Children infected with SARS-CoV-2 are more likely to have viral respiratory co-infections than their SARS-CoV-2-infected adult household contacts, which is surprising in the context of partial lockdown with schools and daycare closed. • When compared to data collected during the same period last year, our study also showed that partial lockdown reduced circulation of common respiratory viruses.

Identifiants

pubmed: 33502627
doi: 10.1007/s00431-021-03947-x
pii: 10.1007/s00431-021-03947-x
pmc: PMC7838463
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1991-1995

Investigateurs

Alain Gervaix (A)
Laurence Lacroix (L)
Kevin Haddad (K)
Klara M Posfay-Barbe (KM)
Noemie Wagner (N)
Arnaud G L'Huillier (AG)
Selina Pinosch (S)
Serge Grazioli (S)
Riccardo Pfister (R)
Barbara Widlhaber (B)
Maurice Beghetti (M)
Albane Maggio (A)

Références

Singleton RJ, Bulkow LR, Miernyk K et al (2010) Viral respiratory infections in hospitalized and community control children in Alaska. J Med Virol 82(7):1282–1290. https://doi.org/10.1002/jmv.21790
doi: 10.1002/jmv.21790 pubmed: 20513097 pmcid: 7167028
Mandelia Y, Procop GW, Richter SS, Worley S, Liu W, Esper F (2020) Dynamics and predisposition of respiratory viral co-infections in children and adults. Clin Microbiol Infect. https://doi.org/10.1016/j.cmi.2020.05.042
Asner SA, Science ME, Tran D, Smieja M, Merglen A, Mertz D (2014) Clinical disease severity of respiratory viral co-infection versus single viral infection: a systematic review and meta-analysis. PLoS One 9(6):e99392. https://doi.org/10.1371/journal.pone.0099392
doi: 10.1371/journal.pone.0099392 pubmed: 24932493 pmcid: 4059637
Kim D, Quinn J, Pinsky B, Shah NH, Brown I (2020) Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA. https://doi.org/10.1001/jama.2020.6266
Nowak MD, Sordillo EM, Gitman MR, Paniz Mondolfi AE (2020) Co-infection in SARS-CoV-2 infected patients: where are influenza virus and rhinovirus/enterovirus? J Med Virol. https://doi.org/10.1002/jmv.25953
Wu Q, Xing Y, Shi L et al (2020) Coinfection and other clinical characteristics of COVID-19 in children. Pediatrics 146(1). https://doi.org/10.1542/peds.2020-0961
Posfay-Barbe KM, Wagner N, Gauthey M et al (2020) COVID-19 in children and the dynamics of infection in families. Pediatrics. https://doi.org/10.1542/peds.2020-1576
L’Huillier AG, Torriani G, Pigny F, Kaiser L, Eckerle I (2020) Culture-competent SARS-CoV-2 in nasopharynx of symptomatic neonates, children, and adolescents. Emerg Infect Dis 26(10). https://doi.org/10.3201/eid2610.202403
Corman VM, Landt O, Kaiser M et al (2020) Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 25(3). https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000045
Stringhini S, Wisniak A, Piumatti G et al (2020) Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. https://doi.org/10.1016/S0140-6736(20)31304-0
Gotzinger F, Santiago-Garcia B, Noguera-Julian A et al (2020) COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc Health. https://doi.org/10.1016/S2352-4642(20)30177-2
Danis K, Epaulard O, Benet T et al (2020) Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020. Clin Infect Dis. https://doi.org/10.1093/cid/ciaa424

Auteurs

Fiona Pigny (F)

Laboratory of Virology, Geneva University Hospitals and Faculty of Medicine, 1211, Geneva, Switzerland.

Noémie Wagner (N)

Pediatric Infectious Diseases Unit, Geneva University Hospitals and Faculty of Medicine, 1211, Geneva, Switzerland.

Marie Rohr (M)

Pediatric Infectious Diseases Unit, Geneva University Hospitals and Faculty of Medicine, 1211, Geneva, Switzerland.

Aline Mamin (A)

Laboratory of Virology, Geneva University Hospitals and Faculty of Medicine, 1211, Geneva, Switzerland.

Pascal Cherpillod (P)

Laboratory of Virology, Geneva University Hospitals and Faculty of Medicine, 1211, Geneva, Switzerland.

Klara M Posfay-Barbe (KM)

Pediatric Infectious Diseases Unit, Geneva University Hospitals and Faculty of Medicine, 1211, Geneva, Switzerland.

Laurent Kaiser (L)

Laboratory of Virology, Centre for Emerging Viral Diseases & Division of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, 1211, Geneva, Switzerland.

Isabella Eckerle (I)

Laboratory of Virology & Centre for Emerging Viral Diseases, Geneva University Hospitals and Faculty of Medicine, 1211, Geneva, Switzerland.

Arnaud G L'Huillier (AG)

Laboratory of Virology, Geneva University Hospitals and Faculty of Medicine, 1211, Geneva, Switzerland. Arnaud.Lhuillier@hcuge.ch.
Pediatric Infectious Diseases Unit, Geneva University Hospitals and Faculty of Medicine, 1211, Geneva, Switzerland. Arnaud.Lhuillier@hcuge.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH